A portfolio spanning industry, EU consortia, NHS Digital, and UK research charities — covering precision-medicine trials, spatial omics, and clinical AI.
Developing a large language-model assistant to support and canvas the concerns of patients with IgAN.
Cell sorting and transcriptomics to resolve divergent immune trajectories in IgAN.
A real-time machine-learning model for in-patients with acute kidney injury, integrated with NHS data infrastructure.
Industry-funded mixed-methods programme: qualitative phenotyping, omics, and complement biology to define a clinically meaningful patient sub-phenotype in IgAN.
Doctoral programme on monocyte and glomerular endothelial-cell contributions to endocapillary hypercellularity in IgAN — using digital spatial profiling and bioinformatics.
Competitive bursary to undertake formal ML training with Data Science Dojo, Barcelona.
Competitive bursary supporting a nephrology elective in Sri Lanka.
UK-wide programme to streamline clinical care and platform-trial research across adult and paediatric glomerular disease.
EU collaborative programme integrating biomarkers and spatial transcriptomics into precision-medicine CKD trials.
Industry-funded programme using spatial transcriptomics and imaging mass spectrometry to identify reversible pathophysiology in glomerular disease.
Cross-disease application of spatial omics to map reversible mechanisms in airway pathology.
Identifying common, druggable pathways between paediatric and adult glomerular disease.
If you’re working on kidney disease research programmes, clinical trials, biomarker strategy, spatial omics, or clinically deployed ML/AI — I’d be glad to talk.
Mayer IgA Nephropathy Laboratories · Hodgkin Building · University of Leicester · LE1 7RH · United Kingdom